- Conditions
- Osteoarthritis
- Interventions
- tanezumab 10 mg, tanezumab 5 mg, naproxen, placebo
- Biological · Drug · Other
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 849 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2010
- U.S. locations
- 95
- States / cities
- Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 69 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–35
of 11
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Arthritis, Osteoarthritis, Osteoarthritis, Hip
- Interventions
- tanezumab, Placebo
- Biological
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years to 99 Years
- Enrollment
- 627 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2010
- U.S. locations
- 99
- States / cities
- Mobile, Alabama • Paradise Valley, Arizona • Peoria, Arizona + 74 more
- Conditions
- Osteoarthritis
- Interventions
- tanezumab
- Biological
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years to 99 Years
- Enrollment
- 2,147 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2011
- U.S. locations
- 226
- States / cities
- Anniston, Alabama • Birmingham, Alabama • Huntsville, Alabama + 148 more
- Conditions
- Osteoarthritis, Cancer Pain, Recurrent Low Back Pain
- Interventions
- Investigational medical product (IMP) administered in parent study
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 0 Years to 2 Months
- Enrollment
- 4 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2020
- U.S. locations
- 6
- States / cities
- Los Angeles, California • Sarasota, Florida • Tampa, Florida + 1 more
- Conditions
- Osteoarthritis Pain, Chronic Low Back Pain, Pain Due to Interstitial Cystitis
- Interventions
- placebo, tanezumab
- Other · Biological
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 28 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2009 – 2010
- U.S. locations
- 2
- States / cities
- Overland Park, Kansas
- Conditions
- Healthy Volunteers
- Interventions
- tanezumab
- Biological
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 76 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008 – 2009
- U.S. locations
- 1
- States / cities
- Cypress, California
- Conditions
- Osteoarthritis
- Interventions
- Tanezumab, Placebo
- Biological · Other
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years to 99 Years
- Enrollment
- 21 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010
- U.S. locations
- 18
- States / cities
- Atlantis, Florida • Fort Myers, Florida • South Miami, Florida + 6 more
- Conditions
- Osteoarthritis
- Interventions
- Investigational Medical Product (IMP) administered in parent study
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 154 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2019
- U.S. locations
- 51
- States / cities
- Birmingham, Alabama • Tucson, Arizona • Little Rock, Arkansas + 36 more
- Conditions
- Cystitis, Interstitial
- Interventions
- PF-04383119, Placebo
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 65 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 34
- States / cities
- Peoria, Arizona • Fresno, California • Glendora, California + 25 more
- Conditions
- Low Back Pain
- Interventions
- Placebo to Week 16; tanezumab 5mg SC, Placebo to Week 16, tanezumab 10 mg SC, Tanezumab 5 mg SC, Tanezumab 10 mg SC, Tramadol PR oral
- Biological
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 1,832 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2018
- U.S. locations
- 179
- States / cities
- Birmingham, Alabama • Mobile, Alabama • Saraland, Alabama + 124 more
- Conditions
- Osteoarthritis, Arthritis
- Interventions
- NSAID, tanezumab
- Drug · Biological
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years to 99 Years
- Enrollment
- 2,720 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2011
- U.S. locations
- 250
- States / cities
- Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 161 more